Guggenheim Restructuring?

Great info solidice thanks

solidice:

Generally, the tiers are: Tier 1: PJT/HL/LAZ ~70%+ of all the meaningful rx deals both in court and out-of-court Tier 2: Moelis, Evercore, Centerview, Ducera (?) Tier 3: Miller Buckfire, PWP, GHL, Jefferies

After that it's all very one off. PWP and GHL used to be good but they are now Ducera. I'd think Guggenheim is in Tier 3, as many of them came from Jefferies, PWP, and Miller Buckfire.

I've seen them at some pitches though.

Dumb.

Moelis is on Tier 1. Houlihan is Tier 1 creditor only. Centerview rx is a failed experiment

Opinion on Millstein?

Also thought that Miller Buckfire has significantly declined

Can you please tell where you would place Duff and Phelps RX? They have been involved in a couple of big transactions including Lehman (as bankruptcy examiner's advisor) and Delphi. Also they seem to have acquired good RX companies in US and UK. In totality, they have grown a lot in last one decade. Any thoughts?

I like this ranking. Although I think Evercore should probably move to Tier 3.

Ducera is Tier 2 (if not currently, then within a few years) and may even get to Tier 1 at some point.